The Valley Desk

NCT05099159 · Interventional trial

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)

Overall registry status Completed

Phase 3

Conditions Hot Flashes, Vasomotor Symptoms Associated With Menopause

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov